Health Care • Medical Specialities
$38.51 ▲ +1.83
(+4.99%)
MKT CAP: $1.18B • VOL: 723.9K
52W L $18 52W H $44
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$32
MEDIAN
$43
MEAN
$44
HIGH
$52
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE CSTL TAPE
CSTL // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $46.60 | $44.29 | 2025-02-14 | $35.04 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $48.52 | $45.44 | 2025-02-06 | $36.20 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $43.90 | $42.36 | 2025-01-29 | $36.97 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $39.28 | — | 2025-01-17 | $37.74 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $33.89 | $36.58 | 2025-01-09 | $34.27 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $45.83 | $40.05 | 2024-12-18 | $33.50 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $37.35 | $38.90 | 2024-12-04 | $35.81 | -4.3% | 48% | C |